QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
1-Year Est. Return
18.39%
1 Year Est. Return
-18.39%
AUM
$23.1M
AUM Growth
-$28M
(-55%)
Holding
6
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tourmaline Bio
TRML
$1.23B
| $11.3M | 48.83% |
741,691
|
|
||
2
Korro Bio
KRRO
$396M
| $6.41M | 27.74% |
368,085
|
|
||
3
Jasper Therapeutics
JSPR
$68.4M
| $3.99M | 17.29% |
928,964
|
|
||
|
HLVX
4
DELISTED
HilleVax
HLVX
| $540K | 2.34% |
372,615
|
|
||
5
Ventyx Biosciences
VTYX
$280M
| $474K | 2.05% |
412,225
|
|
||
6
Kezar Life Sciences
KZR
$46.6M
| $404K | 1.75% |
82,871
|
|